GlassScriptPhysician profile
Walter B Vernon
NPI 1013005024
$7,434.89
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.73 · 2020: $133 · 2023: $3,753 · 2024: $3,519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,960 · Food and Beverage: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,960.00 |
| Food and Beverage | $312.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $6,960.00 | 2023-2024 | |
| Genzyme Corporation | $121.81 | 2020 | |
| Sanofi-Aventis U.S. LLC | $121.60 | 2023 | |
| Axogen | $49.35 | 2023 | Avance Nerve Graft |
| Molli Surgical (US) INC | $37.91 | 2023 | |
| Innovation Technologies INC | $32.81 | 2023 | Irrisept |
| Ethicon US, LLC | $27.93 | 2023 | Echelon; Endopath |
| Calliditas Therapeutics US INC. | $23.86 | 2024 | |
| Tactile Systems Technology INC | $18.73 | 2023 | Flexitouch Plus, Entre Plus |
| Teleflex LLC | $17.42 | 2019 | |
| Optinose US, INC. | $12.31 | 2019 | |
| Smith+Nephew, INC. | $11.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Vernon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.